Suchergebnisse - (Subject:"Pneumonia")

PubPharm (19.260)

101

Dexmedetomidine improves pulmonary outcomes in thoracic surgery under one-lung ventilation : A meta-analysis

enthalten in: Journal of clinical anesthesia | 2024

von Zorrilla-Vaca, A. | Grant, M. | Law, M. | +3

102

Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients : a retrospective cohort study

enthalten in: Internal and emergency medicine | 2024

von Franchi, C. | Rossio, R. | Mandelli, S. | +105

103

Effect of high-frequency repetitive transcranial magnetic stimulation on swallowing function and pneumonia in poststroke dysphagia in rats

enthalten in: Brain research | 2024

von Chen, J. | Zhao, F. | Hong, J. | +5

104

Hypoalbuminemia as predictor of thrombotic events in patients with community-acquired pneumonia

enthalten in: International journal of cardiology | 2024

von Valeriani, E. | Cangemi, R. | Carnevale, R. | +4

105

High-flow nasal oxygen in infants and children for early respiratory management of pneumonia-induced acute hypoxemic respiratory failure: the CENTURI randomized clinical trial

enthalten in: Intensive Care Medicine – Paediatric and Neonatal | 2024

von Kandasamy, S. | Rameshkumar, R. | Sangaralingam, T. | +4

106

Introduction of the pneumococcal conjugate vaccine in humanitarian and fragile contexts : Perspectives from stakeholders in four African countries

enthalten in: Human vaccines & immunotherapeutics | 2024

von Dhaliwal, B. | Weeks, R. | Huber, J. | +6

107

Bacterial etiology of community-acquired pneumonia among adult patients in Ethiopia : A systematic review and meta-analysis

enthalten in: Heliyon | 2024

von Seid, A. | Tadesse, W. | Menza, M. | +2

108

Characteristics of lymphocyte subsets and inflammatory factors in patients with COVID-19

enthalten in: Heliyon | 2024

von Chen, Z. | Li, J. | Zheng, J. | +5

109

Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD : An Observational, Prospective, Multicenter Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD

enthalten in: ClinicalTrials.gov | 2024

110

Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults : A Phase 2, Proof-of-Concept, Multicentre, Open-Label, Randomised, Active-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Rezafungin Combined With 7 Days of Co-Trimoxazole Versus Co-Trimoxazole Monotherapy in HIV-Infected Adults With Pneumocystis Jirovecii Pneumonia

enthalten in: ClinicalTrials.gov | 2024